160 medicines transferred out of health insurance (attached list)

For the province's additions, the next two years will either be successfully transferred to the national health insurance catalog, or leave the health insurance channels, open up new markets, and take the path of zero out-of-pocket or retail.
and with the release of the new document, the provincial supplement has ushered in a new opportunity to enter the national health insurance.
160 drugs, out of the medical insurance on August 3, Anhui Provincial Health Insurance Bureau issued a provincial supplement to class B drugs 2020 digestive drugs public notice.
the document shows that, in accordance with the Notice of the Ministry of Human Resources and Social Security of the State Health Insurance Administration on the Issuance of the National List of Drugs for Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance, "the additional Class B drugs in the original provincial drug catalogue shall be gradually digested within three years."
" requirements, on the basis of full consideration of the drug habits of the insured masses, according to The procurement data of Anhui Province's centralized pharmaceutical procurement platform, the provincial health insurance bureau has drawn up a 2020 plan to digest drugs, which is now publicized: a total of 160 drugs in 2020 were transferred out of Anhui Province medical insurance, including: 1, not in the province's drug mining platform online procurement of drugs 58 2 In 2017-2019, 87 drugs with a purchase volume of "0" and 15 drugs with a purchase volume of "0" in 2019 were transferred from Anhui Province in 2020, with a total of 91 Western medicines, 61 Chinese medicines and 8 ethnic medicines.
Saiber blue combing found that, including Remosjong injections, Zanamiwe inhalers, Qing damicillin slow release control release agents and other Western medicine, bone rib pill capsules, gold hedgehogs nine positive agents, etc. , are due to 19 years of procurement volume of 0 was immediately transferred out of the health insurance directory.
In addition, Western medicines such as cephalosporine tamazole, cephalosporine Shubatan, Ashurive, Daratamwe, compound ammonium glyphosate injection, achimycin oral dispersant, chrysanthemum anti-flu capsules, Yan Corning pills, Sichuan Bay Sydney paste, sleeping brain replacement oral solution and other traditional Chinese medicine, such as the treasure tablets, Ansan town surprise twenty-taste pills, sand ginseng cough soup scattered and other ethnic medicine, because the purchase volume of 3 years is 0 was transferred out of the health insurance directory.
, the National Health Insurance Administration has issued a notice, requiring the end of June to the national key monitoring varieties out of the catalog, and complete the digestion of 40% of provincial varieties.
To this end, Saiber Blue learned that the local updated catalog in accordance with the principle of 442 digested within three years, but did not introduce specific standards and rules;
In fact, many provinces transferred products, some are already relatively thin profit margins, abandoned shell products, or even only the approval number, this Anhui Province transferred, but also most of these products - in a longer period of time there is no procurement volume.
provinces to add varieties, the opportunity came according to Fengyun medicine talk statistics, before 19 provinces have carried out the transfer of provincial supplementary varieties, in addition to the following 17 provinces, there are Henan Province and Hunan Province.
(picture source: Fengyun medicine talk exclusive finishing) from the above-mentioned provinces adjustment situation, the provinces have basically done the key monitoring varieties to take the lead in transferring out of health insurance, but the specific size of the varieties and the corresponding time nodes have some differences.
local supplementary medical insurance catalog of varieties, requiring the transfer of the catalog in batches within three years, the proportion of three-year clean-up varieties are 40%, 40%, 20%, in the next two years, the adjustment of varieties in the provinces will become very critical.
additions, the next two years will either be successfully transferred to the national health insurance catalog, or leave the health insurance channels, open up new markets, and take the path of zero out-of-pocket or retail.
with the release of new documents, the provincial supplement varieties also ushered in the opportunity to enter the national health insurance directory.
, the State Health Insurance Administration released the "2020 National Health Insurance Drug Catalog Adjustment Work Programme (Draft for Comments)" to determine the scope of the new round of medical insurance transfer, transfer out of the variety.
, in particular, proposed that in the 2020 drug catalog to be added to the scope of drugs: by December 31, 2019, into more than 5 (including) the latest provincial version of the medical insurance drug catalog of drugs.
, the main active ingredients were included in the "first batch of national key monitoring of rational drug catalogue" except.
to a certain extent, if a variety appears in more than five provincial supplements by December 31, 2019, as long as it is not a key monitoring variety, it will have the opportunity to enter the 2020 National Health Insurance Drug Catalog.
in the previous Rice network combed, in 2019 China's public medical institutions terminal 37 more than one billion yuan of local health insurance catalog varieties, there are 35 varieties of provincial additions more than 5.
Among them, after excluding the key monitoring varieties, dizoxin injection, injection with serpentine, injection with cephalosporine sodium tamopartate sodium, hydrochloric acid doroubi star liposome injection, injection with yew alcohol liposome, injection with five-water cephalosporine sodium, pwylan anti-inflammatory oral solution, injection with cephalosporine sodium, injection sodium injection Bellaquine sodium, injection of inflammatory amberin, injection of cephalosporine sodium, injection of cyclophosporine glucosamine, injection of cephalosporine sodium Shubatan sodium, large plants of red king-day injection, dichlorite tablets, injection of cephalosporine sodium and other varieties, the supplementary provinces are more than 5, or have the opportunity to enter the 2020 version of national health insurance.
And these varieties, the opportunity to enter the National Health Insurance yesterday documents show that the inclusion of clinically urgently needed overseas list of new drugs, encourage the catalog of generic drugs or encourage research and development of declared children's drugs list, and by December 31, 2019 approved by the State Drug Administration to market drugs, into the scope of adjustment.
the following varieties, it is possible to enter the 2020 health insurance directory.
(Photo source: Fengyun medicine talk) In addition, in the second batch of national collection, Anlishengtan, injection of yew alcohol (albumin-binding type), tadalafin and other self-financing varieties not included in the national health insurance catalog, also entered the scope of adjustment of the health insurance catalog varieties.
Has some research institutions believe that the draft continues to reflect the support and benefits of innovative drugs, the future can meet clinical needs, accurate efficacy, high clinical value of innovative drugs will continue to be favored by health insurance, while the dynamic adjustment mechanism once a year will help innovative drugs approved to market more quickly into the health insurance payment.
Moremore, allowing medical institutions to bargain during the renewal period of health insurance will further assist innovative drug release, as gradient price reductions cover patients who are able to pay from strong to weak at different stages of innovative drug release, and the impact on the industry is far-reaching."
.